UiPath CAO Sells $831K as Stock Outruns Analyst Targets
UiPath's Chief Accounting Officer Hitesh Ramani sold 50,000 shares for $831,250 at $16.50 to $16.75 under a 10b5-1 plan, prices that sit well above the $13.43 consensus analyst target. The stock trade
UiPath CAO Sells $831K as Stock Outruns Analyst Targets
NEW YORK, August 16 —
UiPath, Inc. (PATH) is grinding higher past the consensus analyst price target while its Chief Accounting Officer takes $831,250 off the table, a combination that puts the stock's AI-automation premium under fresh scrutiny. CAO Hitesh Ramani sold 50,000 shares over two consecutive days as the stock sits at $16.01, above the $13.43 consensus target, with 30.3% of float still short.
- Ramani sold 50,000 shares at $16.50, $16.75 on Aug 13-14, generating $831,250 under a 10b5-1 plan.
- Most recent quarter: EPS $0.15 actual vs. estimated, a 5.7% miss; two quarters prior delivered a 19.6% beat.
- Consensus analyst price target is $13.43; short interest is 30.3% of float.
Selling Above the Sell-Side Ceiling
Ramani's two-day exit matters more for its timing than its size. At $16.50 to $16.75 per share, the CAO locked in proceeds at prices that sit well above the $13.43 consensus analyst target. The 10b5-1 plan removes any real-time intent from the read, but the broader context stands out: the most recent quarter was a 5.7% EPS miss, yet the stock has continued grinding higher. With 30.3% of float short, a sizable portion of the market is already positioned against the rally continuing.
The Business Behind the Multiple
UiPath, Inc. builds robotic process automation software that lets enterprises automate repetitive workflows across financial services, healthcare, manufacturing, and the public sector. The platform now layers AI agents and process orchestration through UiPath Maestro alongside traditional RPA, what the company calls agentic enterprise intelligence. Trailing twelve-month revenue reached $1.67 billion, up 17.3% year over year, at an 83% gross margin, and free cash flow was $512 million. With $1.31 billion in cash against $80 million in debt, the balance sheet is solid; the question is whether that growth rate sustains a multiple analysts do not endorse. The DCF calculator can test that assumption.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| PATH | $8.3B | 17.7x | +43.3% |
| AI | $1.5B | n/a | -45.4% |
| UPST | $2.9B | 9.3x | -53.4% |
| U | $20.4B | 26.9x | +20.6% |
| SOUN | $3.3B | n/a | -49.9% |
| SNOW | $114.0B | 121.9x | +65.9% |
The Next Print Is the Test
The next quarterly earnings call is the clearest checkpoint. At 17.7x forward earnings with trailing EPS of $0.60, the multiple implies growth expectations the most recent print did not fully meet; Trefis has noted the stock "carries a market multiple on earnings and a premium on sales," which means a second consecutive miss would close the gap between current prices and analyst fair value more quickly than the current rally implies. Investors should track whether the next EPS print reverses the recent shortfall or extends it. That result will determine whether $16.01 holds. Run the free UiPath, Inc. deep-dive → for the latest numbers.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Why is UiPath's CAO selling shares?
Chief Accounting Officer Hitesh Ramani sold 50,000 shares on Aug 13-14 under a 10b5-1 plan, which removes any real-time trading intent from the transaction. He sold at $16.50 to $16.75 per share, generating $831,250 in total proceeds. The pre-scheduled nature of the sale means it does not necessarily signal a specific view on near-term price direction.
What is UiPath's analyst price target?
The consensus analyst price target for UiPath is $13.43, below the current trading price of $16.01. That gap means the stock is trading above the level most analysts consider fair value. The combination of a recent EPS miss and an above-target share price is the central tension the article examines.
How much did UiPath miss earnings estimates?
UiPath's most recent quarter saw EPS of $0.15 actual versus $0.159 estimated, a 5.7% miss. Two quarters prior, the company delivered a 19.6% beat. The swing from beat to miss, with the stock still trading above analyst consensus, is what makes the next quarterly result the clearest checkpoint for the current valuation.
What is UiPath's short interest?
ectations the most recent print did not fully meet. A second consecutive miss would close the gap between current prices and analyst fair value more quickly than the rally implies.
What does UiPath do as a business?
UiPath builds robotic process automation software that lets enterprises automate repetitive workflows across financial services, healthcare, manufacturing, and the public sector. The platform layers AI agents and process orchestration through UiPath Maestro alongside traditional RPA. Trailing twelve-month revenue reached $1.67 billion, up 17.3% year over year, at an 83% gross margin, with $512 million in free cash flow.
UiPath's Chief Accounting Officer sold 50,000 shares for approximately $831,250 over August 13–14 as the stock sits at $16.01 — above the consensus analyst price target of $13.43. The prescheduled exit arrives alongside a 30.3% short float and a most recent quarter that missed estimates, complicating the narrative around UiPath's recovery.